Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 5
2008 4
2009 3
2010 2
2011 4
2012 5
2013 3
2014 12
2015 12
2016 22
2017 16
2018 16
2019 62
2020 89
2021 100
2022 123
2023 139
2024 179
2025 246
2026 49

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

961 results

Results by year

Filters applied: . Clear all
Page 1
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial.
Della Porta MG, Garcia-Manero G, Santini V, Zeidan AM, Komrokji RS, Shortt J, Valcárcel D, Jonasova A, Dimicoli-Salazar S, Tiong IS, Lin CC, Li J, Zhang J, Pilot R, Kreitz S, Pozharskaya V, Keeperman KL, Rose S, Prebet T, Lai Y, Degulys A, Paolini S, Cluzeau T, Fenaux P, Platzbecker U. Della Porta MG, et al. Among authors: li j. Lancet Haematol. 2024 Sep;11(9):e646-e658. doi: 10.1016/S2352-3026(24)00203-5. Epub 2024 Jul 19. Lancet Haematol. 2024. PMID: 39038479 Clinical Trial.
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Platzbecker U, Della Porta MG, Santini V, Zeidan AM, Komrokji RS, Shortt J, Valcarcel D, Jonasova A, Dimicoli-Salazar S, Tiong IS, Lin CC, Li J, Zhang J, Giuseppi AC, Kreitz S, Pozharskaya V, Keeperman KL, Rose S, Shetty JK, Hayati S, Vodala S, Prebet T, Degulys A, Paolini S, Cluzeau T, Fenaux P, Garcia-Manero G. Platzbecker U, et al. Among authors: li j. Lancet. 2023 Jul 29;402(10399):373-385. doi: 10.1016/S0140-6736(23)00874-7. Epub 2023 Jun 10. Lancet. 2023. PMID: 37311468 Clinical Trial.
Exercise is medicine.
Li J, Qiu H, Li J. Li J, et al. Front Aging Neurosci. 2023 Jan 30;15:1129221. doi: 10.3389/fnagi.2023.1129221. eCollection 2023. Front Aging Neurosci. 2023. PMID: 36793648 Free PMC article. No abstract available.
Self-improving generative foundation model for synthetic medical image generation and clinical applications.
Wang J, Wang K, Yu Y, Lu Y, Xiao W, Sun Z, Liu F, Zou Z, Gao Y, Yang L, Zhou HY, Miao H, Zhao W, Huang L, Zeng L, Guo R, Chong I, Deng B, Cheng L, Chen X, Luo J, Zhu MH, Baptista-Hon D, Monteiro O, Li M, Ke Y, Li J, Zeng S, Guan T, Zeng J, Xue K, Oermann E, Luo H, Yin Y, Zhang K, Qu J. Wang J, et al. Among authors: li j. Nat Med. 2025 Feb;31(2):609-617. doi: 10.1038/s41591-024-03359-y. Epub 2024 Dec 11. Nat Med. 2025. PMID: 39663467
961 results